NVAX
Novavax, Inc.Healthcare$7.70
▲ Bullish
Mkt Cap: $1.25B|Float: 140.5M|SI: 34.6%|DTC: 10.1
Data as of market close Apr 2, 2026
IV Rank
40
IV Pctl
44%
HV 20d
57.9%
52W Range
$5-$12
ATR(14)
$0.60
Exp. Move
±6.0%
P/C Ratio
0.33
Earnings
May 7
GEX Positive
DEX Long
Net Call Premium
IV Moderate
Max Pain Above
Exp. Move Wide
Low Put/Call
NVAX Key Options Data
- IV Rank
- 40.1%
- Total GEX
- $0.01B
- Total DEX
- $5.3M
- Max Pain
- $10.00
- Expected Move
- ±6.0%
- Put/Call OI
- 0.33
- Net Premium
- $0.7M
- Spot Price
- $7.70
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-10 | 8 | ±$0.46 | ±6.0% | $7.24 | $8.16 |
| 2026-04-17 | 15 | ±$0.24 | ±3.2% | $7.45 | $7.94 |
| 2026-04-24 | 22 | ±$0.69 | ±8.9% | $7.01 | $8.38 |
| 2026-05-01 | 29 | ±$2.41 | ±31.3% | $5.29 | $10.11 |
| 2026-05-15 | 43 | ±$1.78 | ±23.1% | $5.92 | $9.48 |
| 2026-07-17 | 106 | ±$2.55 | ±33.1% | $5.15 | $10.25 |
Explore NVAX options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.